We are live on ! Find out more
AKBA icon

Akebia Therapeutics
AKBA

90 hedge funds and large institutions have $209M invested in Akebia Therapeutics in 2015 Q4 according to their latest regulatory filings, with 19 funds opening new positions, 37 increasing their positions, 20 reducing their positions, and 11 closing their positions.

New
Increased
Maintained
Reduced
Closed

318% more call options, than puts

Call options by funds: $1.41M | Put options by funds: $336K

85% more repeat investments, than reductions

Existing positions increased: 37 | Existing positions reduced: 20

73% more first-time investments, than exits

New positions opened: 19 | Existing positions closed: 11

43% more capital invested

Capital invested by funds: $146M → $209M (+$62.8M)

10% more funds holding

Funds holding: 82 → 90 (+8)

Holders
90
Holders Change
+8
Holders Change %
+9.76%
% of All Funds
2.36%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
19
Increased
37
Reduced
20
Closed
11
Calls
$1.41M
Puts
$336K
Net Calls
+$1.07M
Net Calls Change
+$1.28M

Top Buyers

Rank Fund Capital Flow
1
EAM
Eagle Asset Management
Florida
+$7.24M
2
First Manhattan
First Manhattan
New York
+$6.76M
3
VAM
Visium Asset Management
New York
+$4.53M
4
Bank of America
Bank of America
North Carolina
+$3.55M
5
NCM
Nantahala Capital Management
Connecticut
+$2.26M

Top Sellers

Rank Fund Capital Flow
1
NHAS
Novo Holdings A/S
Denmark
-$14.6M
2
CAM
Cormorant Asset Management
Massachusetts
-$969K
3
FWIA
Fort Washington Investment Advisors
Ohio
-$908K
4
EMFAT
Emerald Mutual Fund Advisers Trust
Pennsylvania
-$695K
5
CCI
Columbus Circle Investors
-$627K
Name Holding Trade Value Shares
Change 		Change in
Stake
GGHC
26
Gilder Gagnon Howe & Co
New York
$1.28M +$665K +65,153 +193%
Connor, Clark & Lunn Investment Management (CC&L)
27
Connor, Clark & Lunn Investment Management (CC&L)
British Columbia, Canada
$1.26M +$86.7K +8,500 +10%
BCM
28
Bridgeway Capital Management
Texas
$1.25M – – –
BIM
29
BlackRock Investment Management
Delaware
$1.25M +$18.8K +1,847 +2%
Wells Fargo
30
Wells Fargo
California
$1.19M +$804K +78,841 +592%
UBS Group
31
UBS Group
Switzerland
$1.18M +$592K +57,982 +175%
JIC
32
Johnson Investment Counsel
Ohio
$1.18M -$71.7K -7,026 -7%
TCIM
33
TIAA CREF Investment Management
New York
$1.09M – – –
Charles Schwab
34
Charles Schwab
California
$825K +$16.6K +1,625 +3%
California Public Employees Retirement System
35
California Public Employees Retirement System
California
$762K +$347K +34,000 +136%
ERSOT
36
Employees Retirement System of Texas
Texas
$646K – – –
California State Teachers Retirement System (CalSTRS)
37
California State Teachers Retirement System (CalSTRS)
California
$620K +$37.3K +3,660 +8%
Susquehanna International Group
38
Susquehanna International Group
Pennsylvania
$607K +$480K +47,004 New
EMG
39
Ellington Management Group
Connecticut
$580K +$168K +16,509 +58%
TI
40
Trexquant Investment
Connecticut
$571K -$289K -28,300 -39%
EA
41
Emerald Advisers
Pennsylvania
$554K – – –
Point72 Asset Management
42
Point72 Asset Management
Connecticut
$543K +$429K +42,000 New
LCM
43
Landscape Capital Management
New Jersey
$535K +$422K +41,400 New
AA
44
ALPS Advisors
Colorado
$521K -$48.8K -4,785 -11%
FO
45
FT Options
Illinois
$467K +$369K +36,156 New
TA
46
Teachers Advisors
New York
$455K – – –
RhumbLine Advisers
47
RhumbLine Advisers
Massachusetts
$424K +$10.3K +1,010 +3%
ProShare Advisors
48
ProShare Advisors
Maryland
$367K +$41.3K +4,052 +17%
New York State Common Retirement Fund
49
New York State Common Retirement Fund
New York
$364K -$34.7K -3,403 -11%
CSS
50
Cubist Systematic Strategies
Connecticut
$356K +$281K +27,521 New
1
2
3 4 5

AKBA Hedge Fund Activity: Q4 2015 in Review

90 of the 3,812 institutional investors tracked by Wall St. Rank reported a position in Akebia Therapeutics (AKBA) for Q4 2015, worth a combined $209M — up 43% from $146M a quarter earlier.

Buyers outnumbered sellers: 19 funds opened new AKBA positions and 11 closed out — a net gain of 8 holders — while 37 added to existing stakes and 20 trimmed.

The largest buyer was Eagle Asset Management, adding an estimated $7.24M. The largest seller was Novo Holdings A/S, exiting entirely with an estimated $14.6M sold.

  • 90 institutional investors held Akebia Therapeutics (AKBA) as of Q4 2015, up from 82 in Q3 2015.
  • Funds reported $209M of Akebia Therapeutics stock for Q4 2015, up 43% quarter-over-quarter.
  • 19 funds opened new Akebia Therapeutics positions in Q4 2015 and 11 closed out, a net change of +8 holders.
  • The largest Akebia Therapeutics buyer in Q4 2015 was Eagle Asset Management, an estimated $7.24M added.
  • The largest Akebia Therapeutics seller in Q4 2015 was Novo Holdings A/S, an estimated $14.6M sold.

Based on aggregated 13F filings for Q4 2015.